Literature DB >> 3985075

Race and primary open-angle glaucoma.

M J Martin, A Sommer, E B Gold, E L Diamond.   

Abstract

A comparison of racial distributions for three groups of patients showed that 115 of 140 patients (81.6%) with open-angle glaucoma, 221 of 392 patients (56.4%) with ocular hypertension, and 1,028 of 2,109 patients (48.7%) in a random sample were black. Average age at diagnosis was significantly (P = .006) higher for whites than for blacks (69.1 years vs 63.7 years). Black patients with primary open-angle glaucoma had a significantly larger mean cup-disk ratio (P less than or equal to .002) and a higher but not significantly higher mean intraocular pressure at the time of diagnosis. Advanced glaucomatous visual field loss was more frequent at the time of diagnosis in blacks (43 of 129 patients or 33.3%) than in whites (five of 27 patients or 18.5%), but this difference was not significant.

Entities:  

Mesh:

Year:  1985        PMID: 3985075     DOI: 10.1016/0002-9394(85)90001-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  46 in total

1.  African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes.

Authors:  Lyne Racette; Jeffrey M Liebmann; Christopher A Girkin; Linda M Zangwill; Sonia Jain; Lida M Becerra; Felipe A Medeiros; Christopher Bowd; Robert N Weinreb; Catherine Boden; Pamela A Sample
Journal:  Arch Ophthalmol       Date:  2010-05

2.  Glaucoma screening: too little, too late?

Authors:  A Sommer
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

3.  A 'tent trabeculectomy' (T.T)--surgical alternative for countries of the Third World.

Authors:  R R Berger; E J McGrath
Journal:  Int Ophthalmol       Date:  1992-05       Impact factor: 2.031

Review 4.  Acupuncture for glaucoma.

Authors:  Simon K Law; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

5.  From Machine to Machine: An OCT-Trained Deep Learning Algorithm for Objective Quantification of Glaucomatous Damage in Fundus Photographs.

Authors:  Felipe A Medeiros; Alessandro A Jammal; Atalie C Thompson
Journal:  Ophthalmology       Date:  2018-12-20       Impact factor: 12.079

6.  Interrelations among smoking habits, casual blood pressure and intraocular pressure in middle and old-aged Japanese residents.

Authors:  Yutaka Takashima; Masao Yoshida; Mamoru Ishikawa; Naomi Matsunaga; Yoshiko Uchida; Akatsuki Kokaze; Yasuko Sekine; Yuu Ryu
Journal:  Environ Health Prev Med       Date:  2002-09       Impact factor: 3.674

7.  Glaucoma Care of Prison Inmates at an Academic Hospital.

Authors:  Levi N Kanu; Inae Jang; Daniel J Oh; Manpreet S Tiwana; Amy A Mehta; Mark S Dikopf; Thasarat S Vajaranant; Ahmad A Aref; Deepak P Edward
Journal:  JAMA Ophthalmol       Date:  2020-04-01       Impact factor: 7.389

8.  Family History in the Primary Open-Angle African American Glaucoma Genetics Study Cohort.

Authors:  Joan M O'Brien; Rebecca J Salowe; Raymond Fertig; Julia Salinas; Maxwell Pistilli; Prithvi S Sankar; Eydie Miller-Ellis; Amanda Lehman; Windell H A Murphy; Melissa Homsher; Katelyn Gordon; Gui-Shuang Ying
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

9.  Reductions in Retrobulbar and Retinal Capillary Blood Flow Strongly Correlate With Changes in Optic Nerve Head and Retinal Morphology Over 4 Years in Open-angle Glaucoma Patients of African Descent Compared With Patients of European Descent.

Authors:  Brent Siesky; Alon Harris; Joseph Carr; Alice Verticchio Vercellin; Rehan M Hussain; Priyanka Parekh Hembree; Scott Wentz; Michael Isaacs; George Eckert; Nicholas A Moore
Journal:  J Glaucoma       Date:  2016-09       Impact factor: 2.503

Review 10.  Vascular considerations in glaucoma patients of African and European descent.

Authors:  Andrew Huck; Alon Harris; Brent Siesky; Nathaniel Kim; Michael Muchnik; Priyanka Kanakamedala; Annahita Amireskandari; Leslie Abrams-Tobe
Journal:  Acta Ophthalmol       Date:  2014-01-25       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.